GlaxoSmithKline plc (the 'Company')
Transaction notification
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Mr N Hirons
b)
Position/status
SVP, Global Ethics & Compliance
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
GlaxoSmithKline plc
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
Description of the financial instrument
Ordinary shares of 25 pence each
ISIN: GB0009252882
Nature of the transaction
Following the vesting on 26 August 2016 of an award made on 24 September 2014 under the GlaxoSmithKline Deferred Investment Award Plan, Mr N Hirons will receive a cash payment of £288,000.11 less applicable tax withholding in respect of 17,489 notional ordinary shares.
Price(s) and
volume(s)
Price(s)
Volume(s)
£16.4675
17,489 notional ordinary shares.
d)
Aggregated information
Aggregated volume Price
n/a (single transaction)
e)
Date of the transaction
2016-08-26
f)
Place of the transaction
n/a